• Bridge the Gap

    NewBridge's global business network and unique value proposition provide a platform to bridge the access gap of global innovation and successful reach within the MENA region


  • Accessing Innovation

    NewBridge - a specialty company providing a one stop solution to pharmaceutics, biological, genomics and other innovative healthcare companies seeking to access the MENA markets. 

  • Serving Patients

    NewBridge is committed to providing advanced treatment options through innovative healthcare products to bridge the unmet medical needs of patients in the MENA region

  • 1
  • 2
  • 3


May 19, 2019 12:00 am

NewBridge Pharmaceuticals -2018 winner of the Most Innovative Pharmaceutics Commercialisation Partner MENA award

"The www.CFI.co judging panel applauds the company’s mission to address unmet medical needs in the...

May 11, 2019 12:00 am

NewBridge Pharmaceuticals at WCO-IOF-ESCEO Paris 2019

Joe Henein, the President & CEO of NewBridge Pharmaceuticals, Sherif Hamdy Franchise Head Metabolic Care...

May 1, 2019 12:00 am

NewBridge Pharmaceuticals at EASL 2019

NewBridge President and CEO Joe Henein, Business Director Group Franchise Hisham EL Sayed and Brand...

Accessing Innovation, Serving Patients

NewBridge's global business network, unique value proposition, and its one-stop solution to pharmaceutical, biologics, genomics and other innovative healthcare companies provide a platform both for accessing global innovation – and ensuring successful reach within the MENA Region. NewBridge is committed to bridge the unmet medical needs of, and provide advanced treatment to patients in the Region.


NewBridge provides essential access to build value for pharmaceutics and biotech companies.


NewBridge provides access to innovative therapeutics and diagnostics for patients in the MENA Region


NewBridge has a commercial presence covering 20 plus countries in its network in the MENA Region

  • 1


NewBridge  is a regional specialty company providing a one-stop-solution to pharmaceutics, biological, genomics and other innovative healthcare companies.

Our focus is on in-licensing and commercializing FDA and EMA/European approved innovative therapeutics and diagnostics that address unmet medical needs of diseases with high prevalence within the MENA region.

Our business model is designed to provide the partners we represent with a full range of services and multiple functions to bring long term commercial excellence and build value to our licensed brands across multiple geographies.

Our success is driven by highly talented teams who come to NewBridge with a proven track record and experience in the pharmaceutical industry regionally and globally.



New Bridge Pharmaceuticals

MENA Regional Headquarters
P.O. Box 500618
Business Central Tower A. Floor 18
Dubai Internet City
Dubai, United Arab Emirates
NewBridge Pharmaceuticals Limited
Trident Chambers
PO Box 146 Road Town
British Virgin Islands
NewBridge Alliance Network
Algeria, Bahrain, Egypt, Iraq, Jordan, KSA, Kuwait, Lebanon, Libya, Morocco, Oman , Qatar , Tunisia, UAE, Yemen
In the event of an adverse event occurring from any of the NewBridge licensed products, kindly report them to the NewBridge Safety Mailbox at [email protected]
في حالة حدوث اي اثار جانبية من اي من المنتجات المرخصة لشركة نيوبردج يرجي الابلاغ عنها عن طريق البريد الألكتروني [email protected]